Clinical Trial Update: Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Invobenitug (Procizumab, PCZ, AK1967) for cardiogenic shock is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Invobenitug (Procizumab)

Snippet

Sponsor: 4TEEN4 Pharmaceuticals GmbH | Conditions: Shock, Cardiogenic | Phase 1, Phase 2 | Status: RECRUITING